| Emerging role of exosomes in cancer progression and tumor microenvironment remodeling MDA Paskeh, M Entezari, S Mirzaei, A Zabolian, H Saleki, MJ Naghdi, ... Journal of hematology & oncology 15 (1), 83, 2022 | 375 | 2022 |
| AMPK signaling in diabetes mellitus, insulin resistance and diabetic complications: A pre-clinical and clinical investigation M Entezari, D Hashemi, A Taheriazam, A Zabolian, S Mohammadi, ... Biomedicine & Pharmacotherapy 146, 112563, 2022 | 237 | 2022 |
| Curcumin in cancer therapy: A novel adjunct for combination chemotherapy with paclitaxel and alleviation of its adverse effects M Ashrafizadeh, A Zarrabi, F Hashemi, ER Moghadam, F Hashemi, ... Life sciences 256, 117984, 2020 | 141 | 2020 |
| Anticancer activity of curcumin on human breast adenocarcinoma: Role of Mcl-1 gene ZK Koohpar, M Entezari, A Movafagh, M Hashemi Iranian journal of cancer prevention 8 (3), e2331, 2015 | 137 | 2015 |
| STAT3-EMT axis in tumors: Modulation of cancer metastasis, stemness and therapy response M Sadrkhanloo, M Entezari, S Orouei, M Ghollasi, S Rezaei, ES Hejazi, ... Pharmacological research 182, 106311, 2022 | 123 | 2022 |
| Long non-coding RNA (lncRNA) H19 in human cancer: From proliferation and metastasis to therapy M Hashemi, MS Moosavi, HM Abed, M Dehghani, M Aalipour, EA Heydari, ... Pharmacological research 184, 106418, 2022 | 110 | 2022 |
| EMT mechanism in breast cancer metastasis and drug resistance: Revisiting molecular interactions and biological functions M Hashemi, HZ Arani, S Orouei, S Fallah, A Ghorbani, M Khaledabadi, ... Biomedicine & Pharmacotherapy 155, 113774, 2022 | 101 | 2022 |
| Long non-coding RNAs and exosomal lncRNAs: Potential functions in lung cancer progression, drug resistance and tumor microenvironment remodeling M Entezari, M Ghanbarirad, A Taheriazam, M Sadrkhanloo, A Zabolian, ... Biomedicine & Pharmacotherapy 150, 112963, 2022 | 88 | 2022 |
| Employing siRNA tool and its delivery platforms in suppressing cisplatin resistance: approaching to a new era of cancer chemotherapy S Mirzaei, MH Gholami, F Hashemi, A Zabolian, K Hushmandi, ... Life Sciences 277, 119430, 2021 | 84 | 2021 |
| Biological impact and therapeutic perspective of targeting PI3K/Akt signaling in hepatocellular carcinoma: promises and challenges MDA Paskeh, F Ghadyani, M Hashemi, A Abbaspour, A Zabolian, ... Pharmacological research 187, 106553, 2023 | 81 | 2023 |
| Analysis of the antiproliferative effects of curcumin and nanocurcumin in MDA-MB231 as a breast cancer cell line MH Khosropanah, A Dinarvand, A Nezhadhosseini, A Haghighi, ... Iranian journal of pharmaceutical research: IJPR 15 (1), 231, 2016 | 81 | 2016 |
| Progress in targeting PTEN/PI3K/Akt axis in glioblastoma therapy: Revisiting molecular interactions M Hashemi, S Etemad, S Rezaei, S Ziaolhagh, R Rajabi, P Rahmanian, ... Biomedicine & Pharmacotherapy 158, 114204, 2023 | 78 | 2023 |
| Pre-clinical and clinical importance of miR-21 in human cancers: Tumorigenesis, therapy response, delivery approaches and targeting agents M Hashemi, MSA Mirdamadi, Y Talebi, N Khaniabad, G Banaei, P Daneii, ... Pharmacological Research 187, 106568, 2023 | 78 | 2023 |
| The comparison of anticancer activity of thymoquinone and nanothymoquinone on human breast adenocarcinoma H Dehghani, M Hashemi, M Entezari, A Mohsenifar Iranian journal of pharmaceutical research: IJPR 14 (2), 539, 2015 | 75 | 2015 |
| Electrically conductive biocompatible composite aerogel based on nanofibrillated template of bacterial cellulose/polyaniline/nano-clay MH Salehi, H Golbaten-Mofrad, SH Jafari, V Goodarzi, M Entezari, ... International Journal of Biological Macromolecules 173, 467-480, 2021 | 73 | 2021 |
| Antimutagenicity and anticancer effects of Citrus medica fruit juice M Entezari, A Majd, FA Falahian, S Mehrabian, M Hashemi, ... ACTA MEDICA IRANICA 47 (5), 373-377, 2009 | 64 | 2009 |
| Small in size, but large in action: microRNAs as potential modulators of PTEN in breast and lung cancers AJ Abadi, A Zarrabi, MH Gholami, S Mirzaei, F Hashemi, A Zabolian, ... Biomolecules 11 (2), 304, 2021 | 62 | 2021 |
| Paclitaxel and docetaxel resistance in prostate cancer: Molecular mechanisms and possible therapeutic strategies M Hashemi, MA Zandieh, Y Talebi, P Rahmanian, SS Shafiee, MM Nejad, ... Biomedicine & Pharmacotherapy 160, 114392, 2023 | 60 | 2023 |
| Graphene oxide nanoarchitectures in cancer biology: Nano-modulators of autophagy and apoptosis A Taheriazam, GGY Abad, S Hajimazdarany, MH Imani, S Ziaolhagh, ... Journal of Controlled Release 354, 503-522, 2023 | 60 | 2023 |
| LncRNA-miRNA axis in tumor progression and therapy response: An emphasis on molecular interactions and therapeutic interventions M Entezari, A Taheriazam, S Orouei, S Fallah, A Sanaei, ES Hejazi, ... Biomedicine & Pharmacotherapy 154, 113609, 2022 | 58 | 2022 |